CClinicalTrials.gg
RecruitingNCT06226168Updated May 8, 2024

Effects of Normobaric Hypoxia Exercise Program on Bone Turnover Markers and Metabolism in Premenopausal Women

An interventional study of exercise and environmental conditions and exercise and environmental conditions in Hypoxia, sponsored by University School of Physical Education, Krakow, Poland. Recruiting at 2 sites in Poland. Open to female participants aged 50 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-08.

Sponsored by University School of Physical Education, Krakow, Poland · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 59 Years
Sex
Female
01

Study summary

The impact of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women falls within the realm of physical culture for an active and healthy society. Within this context, the implementation of a project is supported aiming to:

  1. Monitor, support, and promote physical development, fitness, and physical activity in society, by assessing the effects of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women.
  2. Develop and implement innovative methods, forms, and means of physical activation and training for individuals of various ages, by formulating general assumptions of an endurance-strength training concept under normobaric hypoxia conditions, concerning changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women.
  3. Prevent injuries in physical education and sports, by designing a useful training program for osteoporosis prevention as well as for managing carbohydrate and lipid metabolism disorders in premenopausal women.
02

Conditions studied

  • Hypoxia

Browse trials for

Keywords

  • bone turnover
  • carbohydrate metabolism
  • lipid metabolism
  • normobaric hypoxia
03

In context

Hypoxia

1,231 studies on the registry are indexed under Hypoxia; 241 are open to participants now.

This study's planned enrollment of 60 is above the median of 45 across 853 interventional studies indexed under Hypoxia.

Browse Hypoxia studies →

Lead sponsor

University School of Physical Education, Krakow, Poland is the lead sponsor of 20 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 59 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • No significant cardiovascular, respiratory system diseases and musculoskeletal system,
  • No contraindications to physical activity. ECG, baseline urinalysis, morphology are required.
  • T-score within normal limits (+1.0 to -1.0).
  • Informed consent of the patient to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Use of hormone replacement therapy (HRT).
  • Use of substances (cigarettes, alcohol).
  • Any training (including hypoxia training or exposure) performed in the 6 months prior to the beginning of the intervention
  • Any other factors determined by the study investigators as unsuitable for participation.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control group

    The control group will not undergo the training program.

  • Experimental
    Training in normobaric hypoxia

    Training performed under normobaric hypoxia (Week I-1600m above sea level; Week II-1800m above sea level; Week III-2200m above sea level; Week IV-2600m above sea level) and thermoneutral conditions (21°C) and constant humidity (40%).

    Other: exercise and environmental conditions

  • Experimental
    Training in normoxia

    Description: Training performed in normoxia (223 m above sea level) and thermoneutral conditions (21°C) and constant humidity (40%).

    Other: exercise and environmental conditions

  • Experimental
    Passive exposure to normobaric hypoxia

    Passive exposure to normobaric hypoxia conditions (Week I -1600m above sea level; Week II -1800m above sea level; Week III -2200m above sea level; Week IV-2600m above sea level) and thermoneutral conditions (21°C) and constant humidity (40%).

    Other: exercise and environmental conditions

Interventions

  • Otherexercise and environmental conditions

    Participants will perform endurance-strength training for 4 weeks in a variety of environmental conditions. Somatic indices and quantitative indicators of bone mass (bone mineral density) will be measured both before and after the training period. Before the first training day and the day after the last training day, blood will be drawn for biochemical analysis.

  • Otherexercise and environmental conditions

    Passive exposure to normobaric hypoxia conditions. No training intervention. There will be a measurement of selected somatic indices and a quantitative measurement of bone mass indices (bone mineral density). A blood draw for biochemical analysis will be performed.

06

What researchers measure

Primary outcomes

  1. Blood analysis- part 1

    Bone turnover markers: bone-specific alkaline phosphatase (ng/ml), osteocalcin (ng/ml), N-terminal telopeptide of type I collagen (ng/ml), osteoprotegerin (ng/ml), 25-hydroxyvitamin D3 metabolite (ng/ml).

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  2. Blood analysis- part 2

    Hormones of lipid metabolism: adiponectin (μg/mL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  3. Blood analysis- part 3

    Hormones of lipid metabolism: lipid profile (mg/dL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  4. Blood analysis- part 4

    Hormones of lipid metabolism: lipoprotein atherogenicity index (no unit)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  5. Blood analysis- part 5

    Hormones of carbohydrate metabolism: glucose (mg/dL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  6. Blood analysis- part 6

    Hormones of carbohydrate metabolism: insulin (IU/mL), leptin (IU/mL), ghrelin (IU/mL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  7. Blood analysis- part 7

    Thyroid hormones: Thyroid Stimulating Hormone (IU/L)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  8. Blood analysis- part 8

    Vitamins: Vitamin D (ng/mL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  9. Blood analysis- part 9

    Plasma volume changes (ml/kg)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  10. Blood analysis- part 10

    Rheology: viscosity (Pa·s), viscoelasticity (Pa·s)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  11. Blood analysis- part 11

    Rheology: shear rate (s-¹)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  12. Blood analysis- part 12

    Rheology: shear stress (Pa), elastic modulus (Pa)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  13. Blood analysis- part 13

    Blood biochemistry: erythrocytes (million/μL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  14. Blood analysis- part 14

    Blood biochemistry: leukocytes (thousand/μL), platelets (thousand/μL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  15. Blood analysis- part 15

    Blood biochemistry: hemoglobin (g/dL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  16. Blood analysis- part 16

    Blood biochemistry: hematocrit (%), red cell distribution width (%)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  17. Blood analysis- part 17

    Blood biochemistry: mean corpuscular volume (femtoliter)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  18. Blood analysis- part 18

    Blood biochemistry: mean corpuscular hemoglobin (picogram)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  19. Blood analysis- part 19

    Blood biochemistry: mean corpuscular hemoglobin concentration (g/dL), albumin (g/dL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  20. Blood analysis- part 20

    Blood biochemistry: creatinine (mg/dL), bilirubin (mg/dL), blood urea nitrogen (mg/dL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  21. Blood analysis- part 21

    Blood biochemistry: erythrocyte sedimentation rate (mm/h)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  22. Blood analysis- part 22

    Blood biochemistry: alanine aminotransferase (U/L), aspartate aminotransferase (U/L)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  23. Blood analysis- part 23

    Blood biochemistry: ferritin (ng/mL)

    Time frame: Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts

  24. Bone mass- part 1

    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: bone mineral density (g/cm\^2).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  25. Bone mass- part 2

    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: T-score (no unit).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  26. Bone mass- part 3

    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: Z-score (no unit).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  27. Bone mass- part 4

    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: relative skeletal-muscular index (kg/m\^2).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  28. Somatic indicators- part 1

    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: lean body mass (kg).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  29. Somatic indicators- part 2

    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: percentage of body fat (%).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks.

  30. Somatic indicators- part 3

    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: fat mass (kg).

    Time frame: 1 day before and 1 day after the training program. Training will last 4 weeks

07

Study locations

1 of 2 sites recruiting
  • University School of Physical Education in Cracow
    Krakow, 31-571, Poland
    Recruiting
  • University School of Physical Education in Cracow
    Kraków, 31-571, Poland
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06226168
Lead sponsor
University School of Physical Education, Krakow, Poland
Collaborators
Ministry of Education and Science,Poland
Responsible party
Sponsor
First posted
Jan 26, 2024
Start date
May 7, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 8, 2024

Study contacts

Anna Radoń, MSc
Contact
anna.radon@awf.krakow.pl
+45126831142
Małgorzata Bagińska, MSc
Contact
malgorzata.baginska@doctoral.awf.krakow.pl
Małgorzata Bagińska, MSc
principal investigator · Student of Doctoral studies, University of Physical Education in Kraków, Poland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion